Josiah Nelson, MD
Urology · Eau Claire, WINPI 1376595074
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by Teleflex LLC at 34.0% of the total. Reporting peaked in 2024 at $3,431 and has fallen 70.0% since, to $1,028 in 2025. Among urology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $52.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$4K
- Axonics, Inc.$1K
- Neotract Inc.$1K
- Procept Biorobotics Corporation$1K
- Blue Earth Diagnostics$800
- Johnson & Johnson$680
- plus $3K from 34 others
What the payments were for
- Consulting fees$6885%
- Speaking & faculty fees$1751%
- Travel & lodging$5,16741%
- Food & beverage$6,05448%
- Education$4293%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 56 | $4,260 |
| Axonics, Inc. | 12 | $1,465 |
| Neotract Inc. | 10 | $1,379 |
| Procept Biorobotics Corporation | 7 | $1,128 |
| Blue Earth Diagnostics | 9 | $800 |
| Johnson & Johnson | 22 | $680 |
| Intuitive Surgical | 3 | $307 |
| Boston Scientific | 9 | $288 |
| Coloplast | 12 | $213 |
| Astellas Pharma US Inc | 11 | $212 |
| Lumenis, Inc | 1 | $173 |
| AbbVie(2 entities) | 10 | $157 |
| Pfizer | 8 | $150 |
| Sumitomo Pharma America, Inc. | 8 | $146 |
| Bayer | 6 | $110 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $110 |
| Progenics Pharmaceuticals, Inc. | 6 | $105 |
| Dendreon Pharmaceuticals LLC | 6 | $98 |
| Profound Medical Corp. | 1 | $89 |
| Myovant Sciences Inc. | 4 | $70 |
| Urogen Pharma, Inc. | 3 | $61 |
| Endo USA, Inc. | 3 | $45 |
| Urovant Sciences Inc | 3 | $44 |
| Tolmar Pharmaceuticals, Inc. | 3 | $44 |
| Endo Pharmaceuticals Inc. | 3 | $41 |
| Accord Healthcare, Inc. | 2 | $41 |
| Novartis | 2 | $41 |
| Amgen | 2 | $30 |
| Merck | 2 | $30 |
| Sanofi | 2 | $30 |
| Olympus America Inc. | 1 | $20 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| KARL Storz Endoscopy-america | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| AstraZeneca | 1 | $16 |
| Koelis Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Photocure Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$3,627
- Axonics$1,296
- AquaBeam Robotic System$1,025
- UroLift System$994
- Axumin$688
- Bulkamid$589
- Da Vinci Surgical System$276
How this compares
$12,512 in reported general payments places this provider in the 90th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 116 | $75,696 |
| GemtesaVibegron | 29 | $23,079 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 108 | $3,568 |
| Solifenacin Succinate | 78 | $2,398 |
| Tamsulosin Hcl | 163 | $1,950 |
| Testosterone | 11 | $1,533 |
| Tolterodine Tartrate ErTolterodine Tartrate | 18 | $1,123 |
| Finasteride | 81 | $1,117 |
| Oxybutynin Chloride ErOxybutynin Chloride | 31 | $1,075 |
| Trospium Chloride ErTrospium Chloride | 12 | $987 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 74 | $542 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $285 |
| Cephalexin | 23 | $151 |
| Ciprofloxacin Hcl | 53 | $150 |
| Levofloxacin | 41 | $111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $212 | $75,696116 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $146 | $23,07929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 215 urology providers in Wisconsin.
Other urology in Eau Claire
- James IwakiriEau Claire$5K
- Michael HirshEau Claire$3K
- Christopher TornehlEau Claire$3K
- Dan GralnekMadison$142K
- Amy GuiseMilwaukee$106K
- Christopher ManakasMadison$87K
- Bahareh Alavi-DunnGreen Bay$62K
- Javier SantiagoMadison$57K
- Kevin FlynnNeenah$56K
- Margaret KnoedlerMadison$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.